|
KB SRC 4,c-Src抑制剂
|
K288228-50mg
|
≥98%(HPLC) |
1380088-03-8 |
50mg
|
¥ 12319.9
|
现货 |
|
0 |
阿拉丁 |
|
KB SRC 4,c-Src抑制剂
|
K288228-10mg
|
≥98%(HPLC) |
1380088-03-8 |
10mg
|
¥ 3377.9
|
现货 |
|
0 |
阿拉丁 |
|
KCC 07,MBD2(甲基-CpG结合域蛋白2)抑制剂
|
K288208-50mg
|
≥98%(HPLC) |
315702-75-1 |
50mg
|
¥ 716.9
|
现货 |
|
0 |
阿拉丁 |
|
KCC 07,MBD2(甲基-CpG结合域蛋白2)抑制剂
|
K288208-10mg
|
≥98%(HPLC) |
315702-75-1 |
10mg
|
¥ 310.9
|
现货 |
|
0 |
阿拉丁 |
|
KJ Pyr 9,Myc抑制剂
|
K288166-50mg
|
≥95% |
581073-80-5 |
50mg
|
¥ 2374.9
|
现货 |
|
0 |
阿拉丁 |
|
KJ Pyr 9,Myc抑制剂
|
K288166-10mg
|
≥95% |
581073-80-5 |
10mg
|
¥ 690.9
|
现货 |
|
0 |
阿拉丁 |
|
Kisspeptin 10(大鼠)
|
K288066-1mg
|
Moligand™ |
478507-53-8 |
1mg
|
¥ 1896.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
KF 38789,P-选择素介导的细胞粘附的抑制剂
|
K288031-10mg
|
≥97%(HPLC) |
257292-29-8 |
10mg
|
¥ 2297.9
|
现货 |
|
0 |
阿拉丁 |
|
KH 7,腺苷酸环化酶抑制剂
|
K287947-50mg
|
Moligand™, ≥98% |
330676-02-3 |
50mg
|
¥ 3089.9
|
现货 |
|
0 |
阿拉丁 |
|
KH 7,腺苷酸环化酶抑制剂
|
K287947-10mg
|
Moligand™, ≥98% |
330676-02-3 |
10mg
|
¥ 791.9
|
现货 |
|
0 |
阿拉丁 |
|
KML 29,MAGL抑制剂
|
K287859-50mg
|
Moligand™, ≥96% |
1380424-42-9 |
50mg
|
¥ 3271.9
|
现货 |
|
0 |
阿拉丁 |
|
KML 29,MAGL抑制剂
|
K287859-10mg
|
Moligand™, ≥96% |
1380424-42-9 |
10mg
|
¥ 760.9
|
现货 |
|
0 |
阿拉丁 |
|
KW 3902,adenosine A1 receptor拮抗剂
|
K287799-50mg
|
Moligand™, ≥98% |
136199-02-5 |
50mg
|
¥ 6199.9
|
现货 |
|
0 |
阿拉丁 |
|
KW 3902,adenosine A1 receptor拮抗剂
|
K287799-10mg
|
Moligand™, ≥98% |
136199-02-5 |
10mg
|
¥ 1899.9
|
现货 |
|
0 |
阿拉丁 |
|
K-(D-1-Nal)-FwLL-NH2,生长素释放肽受体反向激动剂 TFA 盐
|
K287698-1mg
|
≥98% |
1394288-22-2 |
1mg
|
¥ 599.9
|
现货 |
|
0 |
阿拉丁 |
|
KRCA 0008,Ack1和ALK双重抑制剂
|
K287624-50mg
|
≥98% |
1472795-20-2 |
50mg
|
¥ 552.9
|
现货 |
|
0 |
阿拉丁 |
|
KRCA 0008,Ack1和ALK双重抑制剂
|
K287624-10mg
|
≥98% |
1472795-20-2 |
10mg
|
¥ 162.9
|
现货 |
|
0 |
阿拉丁 |
|
KL 001,蛋白稳定剂
|
K287540-50mg
|
≥98%(HPLC) |
309928-48-1 |
50mg
|
¥ 3953.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
KL 001,蛋白稳定剂
|
K287540-10mg
|
≥98%(HPLC) |
309928-48-1 |
10mg
|
¥ 284.9
|
现货 |
|
0 |
阿拉丁 |
|
KYP 2047,脯氨酰寡肽酶抑制剂
|
K287280-5mg
|
≥98%(HPLC) |
796874-99-2 |
5mg
|
¥ 939.9
|
现货 |
|
0 |
阿拉丁 |
|
KYP 2047,脯氨酰寡肽酶抑制剂
|
K287280-25mg
|
≥98%(HPLC) |
796874-99-2 |
25mg
|
¥ 2629.9
|
现货 |
|
0 |
阿拉丁 |
|
K 02288,1型BMP受体抑制剂
|
K287246-50mg
|
≥98% |
1431985-92-0 |
50mg
|
¥ 1265.9
|
现货 |
|
0 |
阿拉丁 |
|
K 02288,1型BMP受体抑制剂
|
K287246-10mg
|
≥98% |
1431985-92-0 |
10mg
|
¥ 383.9
|
现货 |
|
0 |
阿拉丁 |
|
K 22,抑制冠状病毒RNA复制
|
K287146-50mg
|
≥98%(HPLC) |
2141978-86-9 |
50mg
|
¥ 5408.9
|
期货,请咨询 |
|
0 |
阿拉丁 |